Credit: Acadia Pharmaceuticals. The approval was supported by data from the randomized, double-blind, placebo-controlled phase 3 LAVENDER study. The Food and Drug Administration (FDA) has approved ...

-- First and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000 to 9,000 patients in the U.S. 1 SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc.

The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program ...

CINCINNATI, OHIO, UNITED STATES, March 11, 2023 /EINPresswire.com/ -- The International Rett Syndrome Foundation (IRSF) today joined with the entire Rett syndrome ...

--DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare, neurodevelopmental disorder SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...

Credit: Acadia Pharmaceuticals. Daybue is supplied as a strawberry-flavored oral solution; the product should be refrigerated. Daybue ™ (trofinetide) is now available for the treatment of Rett ...

The Canadian Rett Syndrome Coalition - comprising the Rett Syndrome Society of British Columbia (RSSBC), Rett Syndrome Society of Alberta (RSSA), Saskatchewan Rett Syndrome Association (SRSA), ...

Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for ...

Paige Nues: We have never felt more optimistic than [at] any time in the Rett syndrome’s history in terms of diagnosis today. We have a good idea of what the natural history of Rett syndrome looks ...

Acadia Pharmaceuticals announced last Friday that the FDA approved DAYBUE (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients two years of age and older. DAYBUE is the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted regenerative medicine advanced therapy designation to an intrathecally delivered AAV9 gene ...

A new machine learning model that incorporates cardiac activity and body movement may help estimate the severity of Rett syndrome symptoms, enabling researchers to identify effective treatments, ...